1. Home
  2. KWR vs VERA Comparison

KWR vs VERA Comparison

Compare KWR & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KWR

Quaker Houghton

HOLD

Current Price

$151.43

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$35.45

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
VERA
Founded
1918
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
KWR
VERA
Price
$151.43
$35.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$167.00
$81.30
AVG Volume (30 Days)
141.5K
2.4M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
N/A
EPS
1.13
N/A
Revenue
$1,888,634,000.00
N/A
Revenue This Year
$5.16
N/A
Revenue Next Year
$3.63
$472.48
P/E Ratio
$131.70
N/A
Revenue Growth
2.66
N/A
52 Week Low
$111.42
$19.07
52 Week High
$183.01
$56.05

Technical Indicators

Market Signals
Indicator
KWR
VERA
Relative Strength Index (RSI) 51.24 37.42
Support Level $146.59 $32.48
Resistance Level $155.88 $42.05
Average True Range (ATR) 5.32 2.36
MACD -0.58 -0.89
Stochastic Oscillator 63.41 5.86

Price Performance

Historical Comparison
KWR
VERA

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: